No evidence for PALB2 methylation in high-grade serous ovarian cancer

Rare occurrence of PALB2 mutations in ovarian cancer patients from the Volga-Ural region

(2012) D Prokofyeva et al.   CLINICAL GENETICS

BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

(2012) Kathryn Alsop et al.   JOURNAL OF CLINICAL ONCOLOGY

IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer

(2011) M. S. Anglesio et al.   CLINICAL CANCER RESEARCH

Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer

(2011) Céline Montavon et al.   GYNECOLOGIC ONCOLOGY

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

PARP Inhibitors in BRCA Gene-Mutated Ovarian Cancer and Beyond

(2011) Susana Banerjee et al.   Current Oncology Reports

The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory

(2010) Robert J. Kurman et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast

(2010) Katie T. Huang et al.   BREAST CANCER RESEARCH AND TREATMENT

PALB2/FANCN: Recombining Cancer and Fanconi Anemia

(2010) M. Tischkowitz et al.   CANCER RESEARCH

The implications of heterogeneous DNA methylation for the accurate quantification of methylation

(2010) Thomas Mikeska et al.   Epigenomics

Promoter Hypermethylation of the PALB2 Susceptibility Gene in Inherited and Sporadic Breast and Ovarian Cancer

(2008) A. Potapova et al.   CANCER RESEARCH